Editorās Note: This is part three of a three-part Healio Exclusive series on the development and use of AI to improve clinical outcomes in cardiovascular medicine and considerations for regulatory labeling and patient privacy . Part 1 can be viewed here. Part 2 can be viewed here.
November 8, 2024āAkura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve
BackgroundIntracerebral hemorrhage (ICH) in young adults demands greater attention, given its poor prognosis; however, there has been a paucity of epidemiological data. The objective of…
Der Bluthochdruck, medizinisch die arterielle Hypertonie ist der wichtigste Herzkreislauf Risikofaktor Ć¼berhaupt und raubt weltweit gesehen die meisten Mensc…
The use of 50+Ā year-old donors for heart transplant (HT) is rare in the United States. We assessed reasons for thisāand whether it reflects concern about…
The Texas Heart Institute hosted the 5th Annual Advances in Critical Care Conference, a two-day event held Friday and Saturday, October 11-12, 2024, at The…
CEO of the American Heart Association, Nancy Brown, shares her journey through a health-focused career with Her Agenda.
The availability of cardiac myosin inhibitors (CMI) to treat symptomatic left ventricular outflow tract obstruction (LVOTO) and the evolving recommendation
A 17-year-old male was referred for evaluation by Pediatric Cardiology following a pre-sports medical screening, which revealed abnormal ventricular repola
The American Junior Investigator Association is an organization dedicated to advocacy, career development, and mentorship to optimize the success of diverse early-career physician-scientists to contribute…
